贝康医疗(02170.HK)料中期收入按年增长最多62%

阿斯达克财经07-12

贝康医疗(02170.HK) 公布，截至今年6月底止六个月未经审核收入介乎1.27亿至1.38亿元人民币，按年增长约49%至62%。集团指出，收入增加主要由于收购新加坡BMX Holdco Pte. Ltd.后将其财务业绩合并纳入其全球销售业绩。集团上半年向西班牙、英国、美国等地客户销售的胚胎培养箱等设备及胚胎培养液等产品的销量实现显著增长并成功开发多个集团客户，预期将在下半年实现向多个新客户的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2450346610?lang=zh_CN&edition=full","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220104152656169_s.jpg","is_english":false,"pubTime":"2024-07-12 08:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2450346610","market":"sh","top_or_hot":-1,"title":"贝康医疗(02170.HK)料中期收入按年增长最多62%","media":"阿斯达克财经","content":"<div>\n<p>贝康医疗(02170.HK) 公布，截至今年6月底止六个月未经审核收入介乎1.27亿至1.38亿元人民币，按年增长约49%至62%。集团指出，收入增加主要由于收购新加坡BMX Holdco Pte. Ltd.后将其财务业绩合并纳入其全球销售业绩。集团上半年向西班牙、英国、美国等地客户销售的胚胎培养箱等设备及胚胎培养液等产品的销量实现显著增长并成功开发多个集团客户，预期将在下半年实现向多个新客户的...</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1363125/latest-news/AAFN\">网页链接</a>\n\n</div>\n","source":"aastocks_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>贝康医疗(02170.HK)料中期收入按年增长最多62%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n贝康医疗(02170.HK)料中期收入按年增长最多62%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-12 08:38 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1363125/latest-news/AAFN><strong>阿斯达克财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>贝康医疗(02170.HK) 公布，截至今年6月底止六个月未经审核收入介乎1.27亿至1.38亿元人民币，按年增长约49%至62%。集团指出，收入增加主要由于收购新加坡BMX Holdco Pte. Ltd.后将其财务业绩合并纳入其全球销售业绩。集团上半年向西班牙、英国、美国等地客户销售的胚胎培养箱等设备及胚胎培养液等产品的销量实现显著增长并成功开发多个集团客户，预期将在下半年实现向多个新客户的...</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1363125/latest-news/AAFN\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1574","symbol_name":"生物医药B类股","start_time":0,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1363125/latest-news/AAFN","article_id":"2450346610","we_media_id":null,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220104152656169_s.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2450346610","pubTimestamp":1720744680,"sourceInfo":{"source_id":"aastocks_highlight","name":"阿思達克財經"},"weMediaInfo":null,"summary":"贝康医疗(02170.HK) 公布，截至今年6月底止六个月未经审核收入介乎1.27亿至1.38亿元人民币，按年增长约49%至62%。集团指出，收入增加主要由于收购新加坡BMX Holdco Pte. Ltd.后将其财务业绩合并纳入其全球销售业绩。集团上半年向西班牙、英国、美国等地客户销售的胚胎培养箱等设备及胚胎培养液等产品的销量实现显著增长并成功开发多个集团客户，预期将在下半年实现向多个新客户的产品交付。另预期在辅助生殖领域激励政策的不断推出下，集团在中国的销售规模将会持续增长。贝康医疗预期将于8月刊发中期业绩。(jl/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","collect":0,"end_time":0,"defaultTopTitle":"aastocks.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1574":"生物医药B类股","BK1597":"三胎概念","BK1222":"医疗保健用品","02170":"贝康医疗-B"},"translate_title":"Beikang Medical (02170. HK) expects interim revenue to grow by up to 62% year-on-year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02170":1},"content_text":"贝康医疗(02170.HK) 公布，截至今年6月底止六个月未经审核收入介乎1.27亿至1.38亿元人民币，按年增长约49%至62%。集团指出，收入增加主要由于收购新加坡BMX Holdco Pte. Ltd.后将其财务业绩合并纳入其全球销售业绩。集团上半年向西班牙、英国、美国等地客户销售的胚胎培养箱等设备及胚胎培养液等产品的销量实现显著增长并成功开发多个集团客户，预期将在下半年实现向多个新客户的产品交付。另预期在辅助生殖领域激励政策的不断推出下，集团在中国的销售规模将会持续增长。贝康医疗预期将于8月刊发中期业绩。(jl/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2450346610"}